Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition. (2017)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-17-0261
PubMed Identifier: 28450425
Publication URI: http://europepmc.org/abstract/MED/28450425
Type: Journal Article/Review
Volume: 7
Parent Publication: Cancer discovery
Issue: 9
ISSN: 2159-8274